BE1030789B1 - Oral spray to relieve stress and nervousness - Google Patents
Oral spray to relieve stress and nervousness Download PDFInfo
- Publication number
- BE1030789B1 BE1030789B1 BE20220052A BE202200052A BE1030789B1 BE 1030789 B1 BE1030789 B1 BE 1030789B1 BE 20220052 A BE20220052 A BE 20220052A BE 202200052 A BE202200052 A BE 202200052A BE 1030789 B1 BE1030789 B1 BE 1030789B1
- Authority
- BE
- Belgium
- Prior art keywords
- spray
- essential oil
- spray according
- bud
- vitamin
- Prior art date
Links
- 239000000668 oral spray Substances 0.000 title claims abstract description 29
- 229940041678 oral spray Drugs 0.000 title claims abstract description 26
- 206010029216 Nervousness Diseases 0.000 title claims abstract description 11
- 239000007921 spray Substances 0.000 claims abstract description 31
- 239000000341 volatile oil Substances 0.000 claims abstract description 29
- 229930003231 vitamin Natural products 0.000 claims abstract description 14
- 235000013343 vitamin Nutrition 0.000 claims abstract description 14
- 239000011782 vitamin Substances 0.000 claims abstract description 14
- 229940088594 vitamin Drugs 0.000 claims abstract description 14
- 239000000419 plant extract Substances 0.000 claims abstract description 9
- 208000024891 symptom Diseases 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000000284 extract Substances 0.000 claims description 17
- 240000000783 Origanum majorana Species 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 9
- 241000208340 Araliaceae Species 0.000 claims description 8
- 240000001090 Papaver somniferum Species 0.000 claims description 8
- 235000008753 Papaver somniferum Nutrition 0.000 claims description 8
- 235000003599 food sweetener Nutrition 0.000 claims description 8
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 8
- 239000003765 sweetening agent Substances 0.000 claims description 8
- 235000005979 Citrus limon Nutrition 0.000 claims description 7
- 244000131522 Citrus pyriformis Species 0.000 claims description 7
- 241001672694 Citrus reticulata Species 0.000 claims description 7
- 235000011203 Origanum Nutrition 0.000 claims description 7
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 7
- 235000008434 ginseng Nutrition 0.000 claims description 7
- 235000019160 vitamin B3 Nutrition 0.000 claims description 7
- 239000011708 vitamin B3 Substances 0.000 claims description 7
- 241001165494 Rhodiola Species 0.000 claims description 6
- 240000001890 Ribes hudsonianum Species 0.000 claims description 6
- 235000016954 Ribes hudsonianum Nutrition 0.000 claims description 6
- 235000001466 Ribes nigrum Nutrition 0.000 claims description 6
- 229930003779 Vitamin B12 Natural products 0.000 claims description 6
- 229930003537 Vitamin B3 Natural products 0.000 claims description 6
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 6
- 229960003512 nicotinic acid Drugs 0.000 claims description 6
- 235000019163 vitamin B12 Nutrition 0.000 claims description 6
- 239000011715 vitamin B12 Substances 0.000 claims description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 5
- 239000004383 Steviol glycoside Substances 0.000 claims description 5
- 239000002535 acidifier Substances 0.000 claims description 5
- 235000019411 steviol glycoside Nutrition 0.000 claims description 5
- 229930182488 steviol glycoside Natural products 0.000 claims description 5
- 235000019202 steviosides Nutrition 0.000 claims description 5
- 240000000560 Citrus x paradisi Species 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 235000000346 sugar Nutrition 0.000 claims description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 235000005976 Citrus sinensis Nutrition 0.000 claims description 2
- 240000002319 Citrus sinensis Species 0.000 claims description 2
- 235000020971 citrus fruits Nutrition 0.000 claims description 2
- 150000008163 sugars Chemical class 0.000 claims description 2
- -1 bud macerates Substances 0.000 abstract description 2
- 241000196324 Embryophyta Species 0.000 description 11
- 239000007864 aqueous solution Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 5
- 208000019901 Anxiety disease Diseases 0.000 description 4
- 230000036506 anxiety Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 2
- 235000006297 Origanum majorana Nutrition 0.000 description 2
- 208000002141 Pellagra Diseases 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000002803 maceration Methods 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 208000019116 sleep disease Diseases 0.000 description 2
- 238000001256 steam distillation Methods 0.000 description 2
- 150000008144 steviol glycosides Chemical class 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 208000025721 COVID-19 Diseases 0.000 description 1
- 101100457838 Caenorhabditis elegans mod-1 gene Proteins 0.000 description 1
- 241000698776 Duma Species 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical group [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 101150110972 ME1 gene Proteins 0.000 description 1
- 101100059509 Mus musculus Ccs gene Proteins 0.000 description 1
- 102000006386 Myelin Proteins Human genes 0.000 description 1
- 108010083674 Myelin Proteins Proteins 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 240000004674 Papaver rhoeas Species 0.000 description 1
- 235000007846 Papaver rhoeas Nutrition 0.000 description 1
- 241000218180 Papaveraceae Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940010007 cobalamins Drugs 0.000 description 1
- 150000001867 cobalamins Chemical class 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical group [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002879 macerating effect Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 210000005012 myelin Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Anesthesiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
L'invention se rapporte à un spray buccal à base d'eau, comprenant des extraits secs de plantes, des macérats de bourgeons, des vitamines, et des huiles essentielles. Le spray sert pour traiter ou soulager les symptômes liés au stress et à la nervosité et/ou pour stimuler la relaxation, en particulier la relaxation sommeil.The invention relates to a water-based oral spray, comprising dry plant extracts, bud macerates, vitamins, and essential oils. The spray is used to treat or relieve symptoms related to stress and nervousness and/or to stimulate relaxation, particularly sleep relaxation.
Description
Mod 1 BE2022/0052Mod 1 BE2022/0052
Titre de l’invention : spray buccal pour soulager le stress et la nervositéTitle of the invention: oral spray to relieve stress and nervousness
Domaine technique de l’inventionTechnical field of the invention
La présente invention concerne un spray buccal comprenant des extraits secs de plantes, des macérats de bourgeons, des vitamines et des huiles essentielles.The present invention relates to an oral spray comprising dry plant extracts, bud macerates, vitamins and essential oils.
Ce spray buccal sert à traiter ou soulager les symptômes liés au stress, à l’anxiété et à la nervosité. Ce spray stimule également la relaxation.This oral spray is used to treat or relieve symptoms related to stress, anxiety and nervousness. This spray also stimulates relaxation.
Contexte de l’état de la techniqueBackground of the state of the art
On recherche depuis de nombreuses années dans l’industrie pharmaceutique, des compositions en forme de spray buccal, en général d’origine synthétique contenant de l’alcool, des conservateurs ou du sucre, permettant de traiter ou de soulager les symptômes liés au stress et à la nervosité.For many years, the pharmaceutical industry has been looking for compositions in the form of oral sprays, generally of synthetic origin containing alcohol, preservatives or sugar, making it possible to treat or relieve symptoms linked to stress and to nervousness.
De telles compositions synthétiques provoquent des effets secondaires indésirables.Such synthetic compositions cause undesirable side effects.
Le document intitulé « Air spray with Essential Oils », publiquement accessible surThe document entitled “Air spray with Essential Oils”, publicly accessible on
MINTEL, le 11 mars 2021, de la part de la société Laboratoire Puressentiel sous la rubrique « Rest & Relax » fait référence à un spray pour « provide relaxation, rest and soothe everyday stress ».MINTEL, March 11, 2021, from the company Laboratoire Puressentiel under the heading “Rest & Relax” refers to a spray to “provide relaxation, rest and soothe everyday stress”.
Le document intitulé « Good evening Herb & Fruit Tea », publiquement disponible surThe document entitled “Good evening Herb & Fruit Tea”, publicly available on
MINTEL, le 1 janvier 2015, de la part de la société « Merkur Warenhandels », fait référence à un thé « to forget everyday stress ».MINTEL, January 1, 2015, from the company “Merkur Warenhandels”, refers to a tea “to forget everyday stress”.
Le document intitulé « Prise en charge du stress à l’officine en période COVID-19 » de la part de Justine Auga-Bascou, publiquement disponible le 23 mars 2022 sur internetThe document entitled “Management of stress at the pharmacy during the COVID-19 period” from Justine Auga-Bascou, publicly available on March 23, 2022 on the internet
URL :https://dumas.ccsd.cnrs.fr/dumas-03627244/document, fait référence à une composition pour le traitement de stress, comprenant des vitamines, de la phytothérapie, et de la gemmothérapie.URL: https://dumas.ccsd.cnrs.fr/dumas-03627244/document, refers to a composition for the treatment of stress, including vitamins, herbal medicine, and gemmotherapy.
La demande de brevet Américain publié sous le numéro US 2005/053558 A1, de la part de Arthur Zuckerman, le 10 mars 2005, décrit un dentifrice pour une application sommeil.The American patent application published under number US 2005/053558 A1, from Arthur Zuckerman, on March 10, 2005, describes a toothpaste for a sleep application.
Objet de l’inventionObject of the invention
La présente invention vise à résoudre ces problèmes. Dans ce but, les inventeurs ont entamé des recherches afin de développer un spray buccal pour traiter lesdits problèmes de santé, à base d’ingrédients d’origine purement naturelle, de préférence sans alcool, sans conservateurs et sans sucre.The present invention aims to solve these problems. To this end, the inventors began research to develop an oral spray to treat said health problems, based on ingredients of purely natural origin, preferably without alcohol, without preservatives and without sugar.
Brève description de l’inventionBrief description of the invention
L’invention se rapporte à un spray buccal à base d’eau, comprenant : - des extraits secs de plantes, - des macérats de bourgeons, - des vitamines, et - des huiles essentielles.The invention relates to a water-based oral spray, comprising: - dry plant extracts, - bud macerates, - vitamins, and - essential oils.
Le spray ne contient pas de l’alcool.The spray does not contain alcohol.
De préférence, le spray ne contient pas de sucres, ni des conservateurs.Preferably, the spray does not contain sugars or preservatives.
L’invention, ainsi que ses modes d’application préférés, sont décrits dans les revendications dépendantes annexes.The invention, as well as its preferred modes of application, are described in the appended dependent claims.
D’autres modes de réalisation préférés et avantages de l’invention sont décrits dans la description suivante.Other preferred embodiments and advantages of the invention are described in the following description.
Description détaillée de l’inventionDetailed description of the invention
La présente invention conceme un spray buccal à base d’eau contenant quatre types d’ingrédients : a) des extraits secs de plantes ; b) des macérats de bourgeons ; c) des vitamines ; d) des huiles essentielles.The present invention relates to a water-based oral spray containing four types of ingredients: a) dry plant extracts; b) bud macerates; c) vitamins; d) essential oils.
Plus en particulier, le spray buccal selon l’invention est caractérisé en ce que : a) les extraits secs de plantes comprennent : - un extrait sec de racines de Rhodiole, et/ouMore in particular, the oral spray according to the invention is characterized in that: a) the dry plant extracts comprise: - a dry extract of Rhodiola roots, and/or
3 BE2022/0052 - un extrait sec de pétales de Coquelicot, et/ou - un extrait sec de racines de Ginseng, b) les macérats de bourgeons comprennent : - un macérat de bourgeons de Cassis, et/ou - un macérat de bourgeons de chêne, c) les vitamines comprennent : - la vitamine B3, et/ou - la vitamine B12, d) les huiles essentielles comprennent : - une huile essentielle de Marjolaine à coquilles, et/ou - une huile essentielle d’agrumes choisi entre mandarine, pamplemousse, orange et/ou citron.3 BE2022/0052 - a dry extract of Poppy petals, and/or - a dry extract of Ginseng roots, b) the bud macerates include: - a macerate of Blackcurrant buds, and/or - a macerate of buds of oak, c) the vitamins include: - vitamin B3, and/or - vitamin B12, d) the essential oils include: - an essential oil of Marjoram with shells, and/or - an essential oil of citrus fruits chosen from mandarin , grapefruit, orange and/or lemon.
Selon un mode préféré de l’invention, le spray buccal comprend chacun des ingrédients cités ci-dessus.According to a preferred embodiment of the invention, the oral spray comprises each of the ingredients cited above.
Selon un mode plus préféré de l’invention, le spray buccal selon l’invention comprend en outre un ou plusieurs des ingrédients suivants : - un agent édulcorant ; - un agent acidifiant.According to a more preferred embodiment of the invention, the oral spray according to the invention further comprises one or more of the following ingredients: - a sweetening agent; - an acidifying agent.
Selon un mode préféré de l’invention, le spray buccal comprend : - du glycoside de stéviol en tant qu’agent sucrant ou édulcorant, et/ou - du jus concentré de citron en tant qu’agent acidifiant.According to a preferred embodiment of the invention, the oral spray comprises: - steviol glycoside as a sweetening or sweetening agent, and/or - concentrated lemon juice as an acidifying agent.
Selon un mode préféré de l’invention, le spray buccal comprend les ingrédients suivants dans les quantités indiquées . - de 60 à 95 %, de préf. entre 70 et 95 %, l’eau ; - de 0.1 à 10%, de préf. entre 0,1 à 0,5 %, l’extrait sec de Rhodiola ; - de0.1 à 10%, de préf. entre 0,5 à 2 %, l’extrait sec de Coquelicot ; - de 0.1 à 10%, de préf. entre 0,1 à 0,5 %, l’extrait sec de Ginseng ; - de 0.1 à 5%, de préf. entre 0,2 à 0,5 %, le macérat de bourgeons de Cassis, - de 0.1 à 5%, de préf. entre 0,2 à 0,5 %, le macérat de bourgeons de chêne,According to a preferred embodiment of the invention, the oral spray comprises the following ingredients in the quantities indicated. - from 60 to 95%, preferably between 70 and 95%, water; - from 0.1 to 10%, preferably. between 0.1 to 0.5%, the dry extract of Rhodiola; - from 0.1 to 10%, preferably. between 0.5 to 2%, the dry extract of Poppy; - from 0.1 to 10%, preferably. between 0.1 to 0.5%, the dry extract of Ginseng; - from 0.1 to 5%, preferably. between 0.2 to 0.5%, blackcurrant bud macerate, - from 0.1 to 5%, pref. between 0.2 to 0.5%, oak bud macerate,
4 BE2022/0052 - de 0.01 à 5%, de préf. entre 0,1 à 0,5 %, la vitamine B3 ; - de 0.01 à 5%, de préf. entre 0,01 à 0,2 %, la vitamine B12 ; - de 0.01 à 5 %, de préf. entre 0,01 à 0,2 %, l’huile essentielle de Marjolaine à coquilles ; - de 0.01 à 5%, de préf. entre 0,1 à 0,5 %, l’huile essentielle de mandarine verte ; - de 0.01 à 5%, de préf. entre 0,1 à 0,5 %, l’huile essentielle d’orange douce ; - de 0.01 à 5%, de préf. entre 0,01 à 0,2 %, l’huile essentielle de citron ; - de 0.01 à 5%, de préf. entre 0,1 à 0,5 %, l’huile essentielle de pamplemousse.4 BE2022/0052 - from 0.01 to 5%, preferably between 0.1 to 0.5%, vitamin B3; - from 0.01 to 5%, preferably between 0.01 to 0.2%, vitamin B12; - from 0.01 to 5%, preferably between 0.01 to 0.2%, shell marjoram essential oil; - from 0.01 to 5%, preferably between 0.1 to 0.5%, green mandarin essential oil; - from 0.01 to 5%, preferably between 0.1 to 0.5%, sweet orange essential oil; - from 0.01 to 5%, preferably between 0.01 to 0.2%, lemon essential oil; - from 0.01 to 5%, preferably between 0.1 to 0.5%, grapefruit essential oil.
Ensuite, selon un mode préféré de l’invention, dans le spray buccal : - les extraits végétaux représentent entre 1 et 10 %, de préférence entre 1 et 5 % en poids du spray ; et/ou - les macérats de bourgeons représentent entre 0,1 et 5 %, de préférence entre 0,5 et 1 % en poids du spray ; et/ou - les vitamines représentent entre 0,01 et 1 %, de préférence entre 0,1 et 0,5 % en poids du spray ; et/ou - les huiles essentielles représentent entre 0,01 et 2 %, de préférence entre 0,1 et 1 % en poids du spray.Then, according to a preferred embodiment of the invention, in the oral spray: - the plant extracts represent between 1 and 10%, preferably between 1 and 5% by weight of the spray; and/or - the bud macerates represent between 0.1 and 5%, preferably between 0.5 and 1% by weight of the spray; and/or - the vitamins represent between 0.01 and 1%, preferably between 0.1 and 0.5% by weight of the spray; and/or - essential oils represent between 0.01 and 2%, preferably between 0.1 and 1% by weight of the spray.
Selon un mode encore plus préféré de l’invention, le spray buccal comprend : - du jus concentré de citron en tant qu’agent acidifiant ; - du glycoside de stéviol en tant qu’agent sucrant ou édulcorant.According to an even more preferred mode of the invention, the oral spray comprises: - concentrated lemon juice as an acidifying agent; - steviol glycoside as a sweetening agent or sweetener.
Incorporation du spray buccal dans un flacon aux fins de la pulvérisationIncorporating the oral spray into a bottle for spraying
Afin d’être utilisé en tant que spray, la solution aqueuse qui est à la base du spray buccal selon l’invention, est incluse dans un flacon, de préférence en verre, pourvu d’une pompe, comprenant un bouton poussoir, une buse et (de préférence) un capot.In order to be used as a spray, the aqueous solution which is the basis of the oral spray according to the invention, is included in a bottle, preferably made of glass, provided with a pump, comprising a push button, a nozzle and (preferably) a hood.
Le flacon comporte une simple pompe avec un tube plongeant dans la solution aqueuse et l’utilisateur pulvérise la solution aqueuse dans la bouche via un spray.The bottle has a simple pump with a tube dipping into the aqueous solution and the user sprays the aqueous solution into the mouth via a spray.
La pompe permet de faire remonter la solution aqueuse via le tube plongeant et libère la solution sous forme de spray.The pump allows the aqueous solution to rise via the dip tube and releases the solution in the form of a spray.
La solution aqueuse du spray selon l’invention peut être incluse dans un flacon avec bouton-poussoir.The aqueous solution of the spray according to the invention can be included in a bottle with a push button.
De préférence un tel flacon est fabriqué en verre, et sa capacité est située entre 15 et 30 ml, plus de préférence 20 ml. 5 Un tel flacon peut être pourvu d’une pompe.Preferably such a bottle is made of glass, and its capacity is between 15 and 30 ml, more preferably 20 ml. 5 Such a bottle can be fitted with a pump.
Utilisation du spray buccal :Use of the oral spray:
Le spray buccal selon l’invention peut être utilisé pour traiter ou pour soulager les symptômes liés au stress, à l’anxiété et/ou à la nervositéThe oral spray according to the invention can be used to treat or relieve symptoms linked to stress, anxiety and/or nervousness.
Le spray buccal selon l’invention peut également être utilisé pour stimuler la relaxation.The oral spray according to the invention can also be used to stimulate relaxation.
A ce but, il est recommandé d’utiliser entre deux et cinq, de préférence trois pulvérisations buccales entre deux et cinq, de préférence trois fois par jour.For this purpose, it is recommended to use between two and five, preferably three mouth sprays between two and five, preferably three times a day.
Selon un mode plus préféré de l’invention, les pulvérisations buccales comprennent une dose journalière entre 1 et 3 ml du spray buccal.According to a more preferred embodiment of the invention, the oral sprays comprise a daily dose of between 1 and 3 ml of the oral spray.
Description détaillée de quelques ingrédients du spray buccal selon l’invention :Detailed description of some ingredients of the oral spray according to the invention:
Extrait sec de coquelicotPoppy dry extract
Le coquelicot (Papaver rhoeas) est une plante herbacée qui appartient à la famille des Papaveraceae.The poppy (Papaver rhoeas) is a herbaceous plant that belongs to the Papaveraceae family.
Le coquelicot favorise l’endormissement, et permet de lutter de façon naturelle contre divers troubles du sommeil. L’extrait de coquelicot est capable d’agir contre le stress, l’anxiété, la nervosité, l’agitation.Poppy helps you fall asleep and helps fight various sleep disorders in a natural way. Poppy extract is able to act against stress, anxiety, nervousness, agitation.
Extrait sec de Rhodiola :Rhodiola dry extract:
La Rhodiola (Rosea L.) est une plante adaptogène qui permet d’améliorer la résistance de l’organisme contre la nervosité et le stress.Rhodiola (Rosea L.) is an adaptogenic plant that improves the body's resistance against nervousness and stress.
Extrait sec de Ginseng :Ginseng dry extract:
Le ginseng est une plante vivace qui appartient au genre Panax de la familleGinseng is a perennial plant that belongs to the genus Panax of the family
6 BE2022/0052 des Araliaceae. La racine du ginseng est réputée pour ses propriétés pharmaceutiques et un extrait sec est utilisé en tant que tel dans la solution aqueuse selon l’invention.6 BE2022/0052 of Araliaceae. The root of ginseng is renowned for its pharmaceutical properties and a dry extract is used as such in the aqueous solution according to the invention.
Macérat de bourgeons de Cassis et de Chêne :Blackcurrant and Oak bud macerate:
La solution aqueuse du spray buccal selon l’invention comprend également deux macérats.The aqueous solution of the oral spray according to the invention also comprises two macerates.
Un tel macérât est le résultat d’un procédé qui consiste à faire macérer des plantes pour en extraire les principes actifs. La technique consiste à faire "infuser” une partie d'une plante fraîche ou sèche (fleurs, feuilles, graines, racines… ) dans un mélange eau/ethano! bio/glycérine à température ambiante durant un temps donné (en moyenne un mois).Such a macerate is the result of a process which consists of macerating plants to extract the active ingredients. The technique consists of “infusing” a part of a fresh or dry plant (flowers, leaves, seeds, roots, etc.) in a water/ethano! organic/glycerin mixture at room temperature for a given time (on average one month) .
Lors de cette macération, les principes actifs de la plante sont donc diffusés dans le mélange de solvants pour lui apporter des propriétés complémentaires.During this maceration, the active ingredients of the plant are therefore diffused into the mixture of solvents to provide it with complementary properties.
Ce procédé de macération est appliqué d’une part sur des bourgeons de Cassis, d’autre part sur des bourgeons de chêne.This maceration process is applied on the one hand to blackcurrant buds, and on the other hand to oak buds.
Les résultats de ces deux procédés sont ensuite incorporés dans la solution aqueuse du spray buccal selon l’invention.The results of these two processes are then incorporated into the aqueous solution of the oral spray according to the invention.
Vitamine B3 :Vitamin B3:
La vitamine B3 (CeHsNO2) est une vitamine hydrosoluble qui correspond à deux molécules : la niacine (acide nicotinique) et son amide, la nicotinamide, parfois appelée niacinamide. Elle est aussi appelée vitamine PP pour pellagra preventive car une carence en cette vitamine est responsable de la pellagre.Vitamin B3 (CeHsNO2) is a water-soluble vitamin which corresponds to two molecules: niacin (nicotinic acid) and its amide, nicotinamide, sometimes called niacinamide. It is also called vitamin PP for preventive pellagra because a deficiency in this vitamin is responsible for pellagra.
Vitamine B12Vitamin B12
La vitamine B12, également appelée cobalamine, est une vitamine hydrosoluble, essentielle au fonctionnement normal du cerveau (elle participe à la synthèse des neurotransmetteurs, du système nerveux (elle est indispensable au maintien de l'intégrité du système nerveux et tout particulièrement de la gaine de myéline qui protège les nerfs et optimise leur fonctionnement) et à la formation du sang. C'est l'une des huit vitaminesVitamin B12, also called cobalamin, is a water-soluble vitamin, essential for the normal functioning of the brain (it participates in the synthesis of neurotransmitters, of the nervous system (it is essential for maintaining the integrity of the nervous system and particularly of the sheath of myelin which protects the nerves and optimizes their functioning) and the formation of blood. It is one of the eight vitamins
B.b.
7 BE2022/00527 BE2022/0052
Elle existe sous plusieurs formes appartenant à la famille des cobalamines. Les cobalamines ont une structure chimique proche de l’hème mais l’atome central de fer y est remplacé par un atome de cobalt, d’où leur nom.It exists in several forms belonging to the cobalamin family. Cobalamins have a chemical structure close to heme but the central iron atom is replaced by a cobalt atom, hence their name.
Huile essentielle :Essential oil :
Aux fins de la présente invention on entend par huile essentielle : une essence volatile extraite de plantes aromatiques ou d’organe de cette plante par la distillation par entraînement à la vapeur d'eau.For the purposes of the present invention, essential oil means: a volatile essence extracted from aromatic plants or organs of this plant by distillation by steam distillation.
Huile essentielle de Marjolaine à coquilles :Marjoram essential oil with shells:
La marjolaine (Origanum majorana) est une plante annuelle ou bisannuelle de soixante centimètres, de la famille des Lamiacées et originaire de l’est du bassin méditerranéen.Marjoram (Origanum majorana) is an annual or biennial plant measuring sixty centimeters, from the Lamiaceae family and native to the eastern Mediterranean basin.
Très réputée pour ses vertus calmantes, l'huile essentielle de Marjolaine à coquilles s'utilise pour soulager le stress et l'anxiété et réguler les troubles du sommeil. Le nom botanique est Origanum majorana. La partie de la plante extraite : parties aériennes. Elle est obtenue par distillation complète par entraînement à la vapeur d’eau.Very renowned for its calming properties, Marjoram essential oil is used to relieve stress and anxiety and regulate sleep disorders. The botanical name is Origanum majorana. The part of the plant extracted: aerial parts. It is obtained by complete distillation by steam distillation.
Huile essentielle de Mandarine (verte) :Mandarin essential oil (green):
La Mandarine verte sert à la relaxation et à la détente. Apaisante, elle soulage l’esprit et facilite le sommeil. Le nom botanique est Citrus reticulata Blanco. Partie de la plante extraite : Péricarpes du fruit (zestes) encore verts. Elle est obtenue par Expression à froid puis centrifugation.Green Mandarin is used for relaxation and relaxation. Soothing, it relieves the mind and facilitates sleep. The botanical name is Citrus reticulata Blanco. Part of the plant extracted: Pericarps of the fruit (zest) still green. It is obtained by cold expression then centrifugation.
Glycosides de stéviol :Steviol glycosides:
Les glycosides de stéviol sont les composés chimiques responsables du goût sucré des feuilles de la plante sud-américaine Stevia rebaudiana et les principaux ingrédients de nombreux édulcorants commercialisés sous le nom générique stevia et plusieurs noms commerciaux.Steviol glycosides are the chemical compounds responsible for the sweet taste of the leaves of the South American plant Stevia rebaudiana and the main ingredients of many sweeteners marketed under the generic name stevia and several trade names.
Claims (11)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE20220052A BE1030789B1 (en) | 2022-08-17 | 2022-08-17 | Oral spray to relieve stress and nervousness |
FR2308723A FR3138872A1 (en) | 2022-08-17 | 2023-08-16 | oral spray to relieve stress and nervousness |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE20220052A BE1030789B1 (en) | 2022-08-17 | 2022-08-17 | Oral spray to relieve stress and nervousness |
Publications (2)
Publication Number | Publication Date |
---|---|
BE1030789A1 BE1030789A1 (en) | 2024-03-12 |
BE1030789B1 true BE1030789B1 (en) | 2024-03-18 |
Family
ID=83149556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE20220052A BE1030789B1 (en) | 2022-08-17 | 2022-08-17 | Oral spray to relieve stress and nervousness |
Country Status (2)
Country | Link |
---|---|
BE (1) | BE1030789B1 (en) |
FR (1) | FR3138872A1 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050053558A1 (en) * | 2003-03-18 | 2005-03-10 | Arthur Zuckerman | Sleep inducing toothpaste made with natural herbs and a natural hormone |
-
2022
- 2022-08-17 BE BE20220052A patent/BE1030789B1/en active IP Right Grant
-
2023
- 2023-08-16 FR FR2308723A patent/FR3138872A1/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050053558A1 (en) * | 2003-03-18 | 2005-03-10 | Arthur Zuckerman | Sleep inducing toothpaste made with natural herbs and a natural hormone |
Non-Patent Citations (3)
Title |
---|
AUGA-BASCOU JUSTINE: "Prise en charge du stress à l'officine en période COVID-19", 23 March 2022 (2022-03-23), pages 1 - 89, XP093025662, Retrieved from the Internet <URL:https://dumas.ccsd.cnrs.fr/dumas-03627244/document> [retrieved on 20230220] * |
DATABASE GNPD [online] MINTEL; 11 March 2021 (2021-03-11), ANONYMOUS: "Air Spray with Essential Oils", XP093029320, retrieved from https://www.gnpd.com/sinatra/recordpage/8552321/ Database accession no. 8552321 * |
RECORD ET AL: "Good Evening Herb & Fruit Tea Product Description", 1 January 2015 (2015-01-01), XP093029326, Retrieved from the Internet <URL:https://www.gnpd.com/sinatra/recordpage/3330307/from_search/7aleczCUJ3/?page=1> [retrieved on 20230306] * |
Also Published As
Publication number | Publication date |
---|---|
FR3138872A1 (en) | 2024-02-23 |
BE1030789A1 (en) | 2024-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Alok et al. | Herbal antioxidant in clinical practice: A review | |
TWI494103B (en) | Composition for improving sexual wellness | |
US20090155392A1 (en) | Methods and Systems for Sublingual Guarana Administration | |
KR101498780B1 (en) | Composition for preventing or treating hangover | |
BE1030789B1 (en) | Oral spray to relieve stress and nervousness | |
EP1637149A1 (en) | Dietary supplement composition for the man | |
WO2012007670A2 (en) | Cosmetic or dermatological composition and use thereof for caring for the skin of young men | |
KR100526631B1 (en) | Composition comprising the extract of Morus alba L having monoamine oxidase-inhibiting activity | |
CA2606732C (en) | Composition for preventing and treating hangover | |
EP3672589A1 (en) | Combination product for relieving the symptoms associated with upper respiratory tract infections | |
Kumar et al. | Studies on Preparation and Storage of Aonla Candy Enriched with Different Natural Oil/Extract (Emblica officinails L.) cv. NA-7 | |
Carminative | A review on antimicrobial activity of vegetables, herbs and spices against cariogenic bacteria | |
RU2312657C2 (en) | Mouth cavity rinsing agent | |
KR100749086B1 (en) | A Method for Preparing Extract of Xanthoxylum piperitum and Anti-cariogenic Products Containing Extract of Xanthoxylum piperitum | |
Gillani et al. | Development and Characterisation of Fig (Ficus carica) Leaves Tea with Special Reference to Hypoglycemic Effect: Ficus Leaves Tea for Hypoglycemia | |
KR20140128713A (en) | Perfume Composition Using an Essential Oil Extract of Acorus gramineus and an Essential Oil Extract of Torreya nucifera | |
FR3040628A1 (en) | COMBINATION PRODUCT FOR AIDING RELAXATION AND ENDORTION | |
KR100526628B1 (en) | Composition comprising the extract of Morus alba L having monoamine oxidase-inhibiting activity | |
KR102496534B1 (en) | Functional food composition containing olive tree extract with excellent antioxidant activity as an active ingredient | |
KR102414267B1 (en) | For antioxidant, antidepressant and antistress compositions comprising citrus unshiu peel extract | |
Martini | Borage | |
KR100526629B1 (en) | Composition comprising the extract of Loncera japonica having monoamine oxidase-inhibiting activity | |
KR20100104275A (en) | Composition for improving hepatic function and food composition comprising the same | |
BE1030549A1 (en) | Dietary supplement | |
Saibhavani et al. | Chapter-1 Nutritional Significance of Aloe Vera |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Effective date: 20240318 |